These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2873613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence of tardive dyskinesia: five-year data from a prospective study.
    Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B.
    Psychopharmacol Bull; 1984; 20(1):39-40. PubMed ID: 6144134
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 8. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 9. Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
    Casey DE.
    Adv Biochem Psychopharmacol; 1985 Sep; 40():15-24. PubMed ID: 2862762
    [No Abstract] [Full Text] [Related]

  • 10. Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.
    Kalachnik JE, Harder SR, Kidd-Nielsen P, Errickson E, Doebler M, Sprague RL.
    Psychopharmacol Bull; 1984 Sep; 20(1):27-32. PubMed ID: 6144132
    [No Abstract] [Full Text] [Related]

  • 11. Does clozapine cause tardive dyskinesia?
    Kane JM, Woerner MG, Pollack S, Safferman AZ, Lieberman JA.
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL, Tanner CM, Goetz CG.
    Adv Neurol; 1988 Sep; 49():185-97. PubMed ID: 2894124
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Do atypical antipsychotic agents cause tardive dyskinesia?
    Bailey KP.
    J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 19. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

  • 20. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA.
    Ann Clin Psychiatry; 2006 Dec; 18(1):57-62. PubMed ID: 16517454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.